Gout Drug Raises Safety Concerns With Death Excess in Trial

(MedPage Today) -- Febuxostat linked especially to sudden cardiac deaths in CARES trial
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Gout | Primary Care